Afatinib Recruiting Phase 1 / 2 Trials for Neoplasms, Pancreatic / Neoplasms, Gastrointestinal / Lung Cancer Non-Small Cell Cancer (NSCLC) / Neoplasms, Colorectal Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT03827070Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung Carcinoma